INTERFERON THERAPY OF CRYPTOGENIC CHRONIC ACTIVE LIVER-DISEASE AND ITS RELATIONSHIP TO ANTI-HCV

被引：0
作者：
DIODATI, G
BONETTI, P
TAGGER, A
ALBERTI, A
REALDI, G
RUOL, A
机构：
[1] UNIV MILAN,INST VIROL,I-20122 MILAN,ITALY
[2] UNIV SASSARI,MED GEN CLIN,I-07100 SASSARI,ITALY
来源：
ARCHIVES OF VIROLOGY | 1992年
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In a randomized controlled trial of Interferon (IFN) in 60 patients (30 treated and 30 controls) with cryptogenic chronic active liver disease, 70% of treated patients showed complete response, but a high rate of biochemical relapse (62%) was noted. In these cases, a second response to higher doses of IFN has been more difficult and less frequent. A response to IFN was found in 88.5% of anti-HCV positive treated patients and only in 25% of anti-HCV negative. We suggest that serum anti-HCV is a suitable test to predict the response to IFN.
引用
收藏
页码：299 / 303
页数：5
相关论文
共 50 条
[21]   ANTIBODY TO HEPATITIS-C VIRUS (ANTI-HCV) IN CANADIAN BLOOD-DONORS AND IN PATIENTS WITH CHRONIC LIVER-DISEASE [J].
FEINMAN, SV ;
BLAJCHMAN, MA ;
HERST, R ;
NUSBACHER, J ;
BERRIS, B ;
SCHROEDER, ML .
HEPATOLOGY, 1990, 12 (04) :877-877
[22]   ANTI-HCV IS CONFIRMED BY RECOMBINANT IMMUNOBLOTTING ASSAY (RIBA) IN CHRONIC ACTIVE LIVER-DISEASE ASSOCIATED WITH BLOOD-TRANSFUSION, AUTOANTIBODIES OR HEAVY ALCOHOLIC INTAKE [J].
BALDI, M ;
MANZINI, P ;
OLIVERI, F ;
LAVARINI, C ;
BRUNETTO, MR ;
TOUSCOZ, G ;
SARACCO, G ;
RIZZETTO, M ;
VERME, G ;
BONINO, F .
HEPATOLOGY, 1990, 12 (04) :960-960
[23]   AMYLOIDOSIS OF LIVER - ITS ASSOCIATION WITH CHRONIC ACTIVE LIVER-DISEASE [J].
CASARI, MG ;
FEDERZONI, G .
GIORNALE DI GERONTOLOGIA, 1977, 25 (09) :861-870
[24]   HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV [J].
ALBERTI, A ;
MORSICA, G ;
CHEMELLO, L ;
CAVALLETTO, D ;
NOVENTA, F ;
PONTISSO, P ;
RUOL, A .
LANCET, 1992, 340 (8821) :697-698
[25]   UNSUSPECTED CELIAC-DISEASE IN CHRONIC CRYPTOGENIC LIVER-DISEASE [J].
LINDGREN, S ;
SJOBERG, K ;
ERIKSSON, S .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (07) :661-664
[26]   Interferon-Free Sofosbuvir-Based Anti-HCV Therapy After Liver Transplantation [J].
Seifert, Leon Louis ;
Vorona, Elena ;
Bester, Caroline ;
Stahl, Martin ;
Huesing, Anna ;
Beckebaum, Susanne ;
Kabar, Iyad ;
Heinzow, Hauke ;
Schmidt, Hartmut H. -J. .
ANNALS OF TRANSPLANTATION, 2015, 20 :561-568
[27]   RESISTANCE TO ALPHA-INTERFERON (IFN) THERAPY IN HCV CHRONIC LIVER-DISEASE - ROLE OF HEPATIC-FIBROSIS [J].
DICOSTANZO, GG ;
ASCIONE, A ;
LANZA, AG ;
SERGIO, A ;
BRACCO, A ;
LOJODICE, D .
HEPATOLOGY, 1994, 20 (04) :A294-A294
[28]   Different anti-HCV profiles of statins and their potential for combination therapy with interferon [J].
Ikeda, Masanori ;
Abe, Ken-ichi ;
Yamada, Masashi ;
Dansako, Hiromichi ;
Naka, Kazuhito ;
Kato, Nobuyuki .
HEPATOLOGY, 2006, 44 (01) :117-125
[29]   INTERFERON-FREE ANTI-HCV THERAPY AFTER ORGAN TRANSPLANTATION [J].
Stauber, R. ;
Stadlbauer, V. ;
Spindelboeck, W. ;
Rainer, F. ;
Posch, A. ;
Streit, A. ;
Jakoby, E. ;
Kniepeiss, D. ;
Mueller, H. .
TRANSPLANT INTERNATIONAL, 2015, 28 :11-11
[30]   CHRONIC HEPATITIS-C RESPONSE TO INTERFERON THERAPY - COMPARISON OF ALT NORMALIZATION WITH ANTI-HCV IGM, ANTI-HCV IGG, AND HCV-RNA POLYMERASE CHAIN-REACTION [J].
DOUGLAS, DD ;
RAKELA, J ;
LIN, HJ ;
TASWELL, HF ;
CZAJA, AJ ;
RABE, D ;
HOLLINGER, FB .
HEPATOLOGY, 1991, 14 (04) :A74-A74
12345